[1] Asano N,Kato S,Nakamura S. Epstein-Barr virus-associated natural killer/T-cell lymphomas[J]. Best Pract Res Clin Haematol,2013,26(1):15-21. [2] Knecht H,Berger C,Rothenberger S,et al. The role of Epstein-Barr virus in neoplastic transformation[J]. Oncology, 2001,60(4):289-302. [3] Tsao SW,Tsang CM,To KF,et al. The role of Epstein-Barr virus in epithelial malignancies[J]. J Pathol,2015,235(2): 323-333. [4] Hu LF,Zabarovsky ER,Chen F,et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma[J]. J Gen Virol,1991,72 (Sup 10):2399-2409. [5] Kingma DW,Weiss WB,Jaffe ES,et al. Epstein-Barr virus latent membrane protein-1 oncogene deletions:correlations with malignancy in Epstein-Barr virus-associated lympho-proliferative disorders and malignant lymphomas[J]. Blood, 1996,88(1):242-251. [6] Guiretti DM,Chabay PA,Valva P,et al. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas[J]. J Med Virol,2007,79(11):1722-1730. [7] Edwards RH,Sitki-Green D,Moore DT,et al. Potential selection of LMP1 variants in nasopharyngeal carcinoma[J]. J Virol,2004,78(2):868-881. [8] Saechan V,Mori A,Mitarnun W,et al. Analysis of LMP1 variants of EBV in Southern Thailand:evidence for strain-associated T-cell tropism and pathogenicity[J]. J Clin Virol, 2006,36(2):119-125. [9] Knecht H,Bachmann E,Brousset P,et al. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders [J]. Oncogene,1995,10 (3):523-528. [10] Zhou XG,Sandvej K,Li PJ,et al. Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors:identification of three distinct virus variants[J]. J Gen Virol,2001,82(5):1157-1167. [11] Khanim F,Yao QY,Niedobitek G,et al. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations[J]. Blood, 1996,88 (9):3491-3501. [12] Zhang XS,Song KH,Mai HQ,et al. The 30-bp deletion variant:a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China[J]. Cancer Lett,2002,176 (1):65-73. [13] Edwards RH,Seillier-Moiseiwitsch F,Raab-Traub N. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains[J]. Virology,1999, 261(1):79-95. [14] Miller WE,Edwards RH,Walling DM,et al. Sequence variation in the Epstein-Barr virus latent membrane protein 1[J]. J Gen Virol,1994,75 (Sup 10):2729-2740. [15] 王 云. EBV相关肿瘤中病毒基因多态性研究[D]. 青岛:青岛大学医学院,2010. [16] Nagamine M,Takahara M,Kishibe K,et al. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma[J]. Virus Genes,2007,34(1):47-54. [17] Chiang AK,Wong KY,Liang AC,et al. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues:implications on virus strain selection in malignancy[J]. Int J Cancer,1999,80(3): 356-364. [18] Huang YH,Wu QL,Zong YS,et al. Nasopharyngeal extranodal NK/T-cell lymphoma,nasal type:retrospective study of 18 consecutive cases in Guangzhou,China[J]. Int J Surg Pathol,2011,19(1):51-61. [19] 赵 莎,刘卫平,王晓凌,等. 结外鼻型NK/T细胞淋巴瘤中EB病毒潜伏膜蛋白1基因30 bp碱基缺失的检测意义及与预后的关系[J]. 中华病理学杂志,2005,34(11):720-723. [20] Kuo TT,Shih LY,Tsang NM. Nasal NK/T cell lymphoma in Taiwan:a clinicopathologic study of 22 cases,with analysis of histologic subtypes,Epstein-Barr virus LMP-1 gene association, and treatment modalities[J]. Int J Surg Pathol,2004,12(4): 375-387. [21] Kim JE,Kim YA,Jeon YK,et al. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea:Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1[J]. Pathol Int,2003,53(11):735-743. [22] Tai YC,Kim LH,Peh SC. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract[J]. Pathol Int,2004,54(3):158-166. [23] Cabrera ME,Eizuru Y,Itoh T,et al. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile[J]. J Clin Pathol,2007,60(6): 656-660. [24] Chang CM,Yu KJ,Mbulaiteye SM,et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns:a need for reappraisal[J]. Virus Res,2009, 143(2):209-221. [25] Lo AK,Huang DP,Lo KW,et al. Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells[J]. Int J Cancer,2004,109(6):919-925. [26] Blake SM,Eliopoulos AG,Dawson CW,et al. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity[J]. Virology,2001,282(2):278-287. |